Traber; Peter G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Traber; Peter G..The latest application filed is for "composition of novel carbohydrate drug for treatment of human diseases".

Company Profile

9.18.23

Traber; Peter G. - Duluth GA
Traber; Peter G. - Alpharetta GA
Traber; Peter G. - Gladwyne PA
Traber; Peter G. - Johns Creek GA
Traber; Peter G. - Norcross GA
Traber; Peter G. - Norcros GA
Traber; Peter G. - San Jose CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treatment of arthritis Grant 11,413,303 - Zomer , et al. August 16, 2	2022-08-16
Composition of Novel Carbohydrate Drug for Treatment of Human Diseases App 20210093656 - Zomer; Eliezer ; et al.	2021-04-01
Composition of novel carbohydrate drug for treatment of human diseases Grant 10,799,525 - Zomer , et al. October 13, 2	2020-10-13
Compounds for the Prevention and Treatment of Diseases and the Use Thereof App 20200155586 - Zomer; Eliezer ; et al.	2020-05-21
Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof App 20200147088 - Nir; Raphael ; et al.	2020-05-14
Composition of Novel Carbohydrate Drug for Treatment of Human Diseases App 20200078390 - Zomer; Eliezer ; et al.	2020-03-12
Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof App 20200061095 - Traber; Peter G. ; et al.	2020-02-27
Selenogalactoside Compounds For The Prevention And Treatment Of Diseases Associated With Galectin And The Use Thereof App 20190367552 - Shechter; Sharon ; et al.	2019-12-05
Composition of novel carbohydrate drug for treatment of human diseases Grant 10,420,793 - Zomer , et al. Sept	2019-09-24
Method for enhancing specific immunotherapies in cancer treatment Grant 10,398,778 - Traber , et al. Sep	2019-09-03
Composition of Novel Carbohydrate Drug for Treatment of Human Diseases App 20180256626 - Zomer; Eliezer ; et al.	2018-09-13
Method for Enhancing Specific Immunotherapies in Cancer Treatment App 20180236084 - Traber; Peter G. ; et al.	2018-08-23
Composition of novel carbohydrate drug for treatment of human diseases Grant 9,974,802 - Zomer , et al. May 22, 2	2018-05-22
Method for treatment of pulmonary fibrosis Grant 9,968,631 - Traber May 15, 2	2018-05-15
Method for enhancing specific immunotherapies in cancer treatment Grant 9,872,909 - Traber , et al. January 23, 2	2018-01-23
Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase Grant 9,763,974 - Traber , et al. September 19, 2	2017-09-19
Composition Of Novel Carbohydrate Drug For Treatment Of Human Diseases App 20170202870 - Zomer; Eliezer ; et al.	2017-07-20
Composition of novel carbohydrate drug for treatment of human diseases Grant 9,649,327 - Zomer , et al. May 16, 2	2017-05-16
Method For Treatment Of Pulmonary Fibrosis App 20160213703 - Traber; Peter G.	2016-07-28
Method for treatment of pulmonary fibrosis Grant 9,339,515 - Traber May 17, 2	2016-05-17
Composition Of Novel Carbohydrate Drug For Treatment Of Human Diseases App 20150174151 - Zomer; Eliezer ; et al.	2015-06-25
Galacto-rhamnogalacturonate Compositions For The Treatment Of Diseases Associated With Elevated Inducible Nitric Oxide Synthase App 20150147338 - Traber; Peter G. ; et al.	2015-05-28
Composition of novel carbohydrate drug for treatment of human diseases Grant 8,962,824 - Zomer , et al. February 24, 2	2015-02-24
Composition Of Novel Carbohydrate Drug For Treatment Of Human Diseases App 20140350238 - Zomer; Eliezer ; et al.	2014-11-27
Compositions of novel carbohydrate drug for treatment of human diseases Grant 8,871,925 - Zomer , et al. October 28, 2	2014-10-28
Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders Grant 8,828,971 - Traber , et al. September 9, 2	2014-09-09
Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders App 20140099319 - Traber; Peter G.	2014-04-10
Method For Enhancing Specific Immunotherapies In Cancer Treatment App 20140086932 - Traber; Peter G. ; et al.	2014-03-27
Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease Grant 8,658,787 - Traber , et al. February 25, 2	2014-02-25
Galactomannan polysaccharide composition for the treatment of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease App 20130259870 - Traber; Peter G. ; et al.	2013-10-03
Compositions of novel carbohydrate drug for treatment of human diseases App 20130261078 - Zomer; Eliezer ; et al.	2013-10-03
Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease App 20130171151 - Traber; Peter G. ; et al.	2013-07-04
Methods and apparatus for centrifugal liquid chromatography Grant 8,293,100 - Kerr , et al. October 23, 2	2012-10-23
Methods And Apparatus For Centrifugal Liquid Chromatography App 20100230354 - Kerr; Robert R. ; et al.	2010-09-16

Company Registrations

SEC

0001284500

TRABER PETER G

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.